2019.02.18 FDA 510(k) The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]
2022.02.08 Part11 FDA CDER「Use of Electronic Records and Electronic Signatures in Clinical Investigations Under 21 CFR Part 11 – Questions and Answers」